Tag: Bharat Biotech

Covaxin team of Bharat Biotech to receive Bhramara Trust Award
News

Covaxin team of Bharat Biotech to receive Bhramara Trust Award

December 23, 2022

Mysore/Mysuru: The Science team of Bharat Biotech that developed the Covaxin has been selected to receive Bhramara’s Prestigious Award for Distinguished Service to Humanity instituted by the Bhramara Trust of Y.T. and Madhuri Thathachari, Mysuru. “The Covaxin team of Bharat Biotech has made the whole country proud by developing this vaccine. Covaxin is the result…

City child dressed as ‘Covaxin’ impresses Bharat Biotech
News

City child dressed as ‘Covaxin’ impresses Bharat Biotech

November 11, 2021

Mysore/Mysuru: Bharat Biotech last week celebrated Covaxin’s Emergency Use Listing (EUL) by the World Health Organisation (WHO), two days after the global health organisation gave the much-anticipated nod to India’s indigenous vaccine. While celebrating the go-ahead given to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech in partnership with ICMR and the National Institute of…

11,200 Covaxin doses arrive in city
Coronavirus Update, COVID-19, News

11,200 Covaxin doses arrive in city

March 12, 2021

To be administered at JSS Hospital and Trauma Care Centre  Mysore/Mysuru: As many as 11,200 doses of Covaxin, India’s indigenous COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), has arrived in Mysuru last evening. It will be administered to citizens above…

Covaxin protects against mutated Coronavirus
Coronavirus Update, COVID-19, News

Covaxin protects against mutated Coronavirus

December 30, 2020

Hyderabad: Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of Coronavirus, said Krishna Ella, Chairman and Managing Director of the city-based vaccine maker, on Tuesday. He also said the company had approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration…

Namma Mysuru connection for desi Covaxin
Coronavirus Update, COVID-19, News

Namma Mysuru connection for desi Covaxin

December 19, 2020

Bharat Biotech Joint Managing Director says it may cost around Rs.300 per dose; Committed to distribute vaccine to ‘Bharat’ first Mysore/Mysuru: All know that Hyderabad-based Bharat Biotech is involved in developing Covaxin, a possible vaccine for the dreaded COVID-19 pandemic. But hardly a few know that two persons behind this company had stayed in ‘Namma…

Covaxin: First part of Phase-1 results  ‘encouraging’, says Rohtak PGIMS
COVID-19, News

Covaxin: First part of Phase-1 results ‘encouraging’, says Rohtak PGIMS

July 28, 2020

New Delhi: While Phase-1 human trials of Bharat Biotech’s Covaxin, India’s first indigenous COVID-19 vaccine candidate, are on at most of the 12 sites selected by Indian Council of Medical Research (ICMR) across the country, the Post-Graduate Institute of Medical Sciences (PGIMS), Rohtak, has claimed “encouraging” results from first part of tests. Earlier this week,…

ABOUT

Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 41 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.

CONTACT

Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Online Edition: [email protected]
Print Editon: [email protected]
For News/Press Release: [email protected]